| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
482
|
93
|
10,440
|
493
| | Cost of Revenue | 6,312 | 1,429 |
-
|
-
| | |
Gross Profit
|
(5,830)
|
(1,336)
|
10,440
|
493
| |
|
Operating Expenses |
|
Research Development | 1,843 | 2,918 | 3,057 | 2,859 |
|
Selling General and Administrative | 2,802 | 2,265 | 2,483 | 2,731 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(10,475)
|
(6,519)
|
4,900
|
(5,097)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | (10,500) | (6,554) | 4,855 | (5,140) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (10,500) | (6,554) | 4,855 | (5,140) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (10,500) | (6,554) | 4,855 | (5,140) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(10,500)
|
(6,554)
|
4,855
|
(5,140)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(10,500)
|
(6,554)
|
4,855
|
(5,140)
|
|
0.05(1.58%) 2:52PM EDT - Nasdaq Real Time Price